Table 2.

Patient Characteristics and Distribution by Protocol (n=237)

Characteristic	N (%ˆ)
No. of Patients	237
Age at Diagnosis (years)
Median	13.7
Range	1.1-25.2
Sex
Male	144 (60.8)
Female	93 (39.2)
Race
Caucasian	218 (92.0)
African-American	11 (4.6)
Hispanic	6 (2.5)
Other races	2 (0.8)
Stage at Diagnosis
Localized	172 (72.6)
Metastatic	65 (27.4)
Local Control Measures
Surgery alone	49 (20.7)
Radiation alone	128 (54.0)
Surgery and radiation	58 (24.5)
No local control	2 (0.8)
Treatment Protocol
ES79	80 (33.8)
ES87	46 (19.4)
EWI92	49 (20.7)
HIRISA1/2	11 (4.6)
POG9354	13 (5.5)
SJBCM*	38 (16.0)

^ˆPercentages may not sum to 100% due to rounding

^*15 patients in this group received first 12 weeks of therapy on pegfilgrastim study.